CRDL
Cardiol Therapeutics Inc.
$1.05
+0.00 (+0.00%)
At close · Jul 2
Market Cap
$121.04M
Shares
100,257,009
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.05
Open$1.04
Day$1.04–1.09
52W$0.88–1.71
Avg vol 30d333K
Short int2.1M · 2.1% float · 5.2d
Short vol26%
DataJan 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−6% below
−
Price vs 50-day avg
−14% below
◦
RSI (14)
38 · neutral
+
MACD trend
positive
◦
52-week position
20% · mid-range
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $1 › 200d $1 — 50d above 200d
◦
Institutional flow
1 of 47 funds reported for Jun 30 · net 0 sh shares
◦
Insider flow
No net insider activity over 90 days
−
Short interest
2.08% of float · ▲ +8.6% MoM · 5.2 days cover
◦
Volume signal
Volume near normal
+
Institution breadth
47 holders — near 3-yr high, broad support
Fundamentals
Limited data
Not enough data for a confident read.
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−6% below
Bearish
Price vs 50-day avg
−14% below
Bearish
RSI (14)
38 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
20% · mid-range
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow
Flat
1 of 47 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.08% of float · ▲ +8.6% MoM · 5.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
47 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $1 · 20%
52-wk high $2
vs 200-day avg -6%
vs 50-day avg -14%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CRDL
this stock
Cardiol Therapeutics Inc.
|
$121.04M | +10.1% | — | — | 2.1% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$52.99B | +7.6% | — | — | 0.3% |
|
GALDY
Galderma Group AG/ADR
|
$52.48B | +8.0% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.25B | -2.9% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CRDL | +1.0% | -6.3% | +5.0% | -0.9% | +10.1% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -0.5% | -5.0% | -3.0% | -0.7% | +0.8% |